Browsing by Subject "A61P 19/02"
Now showing items 1-2 of 2
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-09-04)The present invention provides compounds having the general structure A, or a pharmaceutically acceptable derivatives thereof: wherein R is an alkyl group, and R1 comprises at least one moiety selected from a group ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-12-18)Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.